Overview of Dr. Bruce
Dr. Jeffrey Bruce is a neurosurgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 34 years. Dr. Bruce accepts several types of health insurance, listed below. He is one of 131 doctors at New York-Presbyterian Hospital and one of 54 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.
Office
710 West 168th Street
New York, NY 10032- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 1985 - 1990
- Clinical Center at the National Institutes of HealthResidency, Neurological Surgery, 1984 - 1985
- New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1983 - 1984
- Rutgers Robert Wood Johnson Medical SchoolClass of 1983
Certifications & Licensure
- NJ State Medical License 1993 - 2025
- NY State Medical License 1989 - 2024
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2020
- New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2011-2014, 2017-2020
- America's Top Doctors for Cancer Castle Connolly, 2005-2020
- Join now to see all
Clinical Trials
- Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors Start of enrollment: 2004 Mar 01
- A Phase I Study of Topotecan by Convection Enhanced Delivery (Intracerebral Clysis) for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Sep 01
- A Phase I/II Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer's disease.Haage, V., Tuddenham, J., Comandante-Lou, N., Bautista, A., Monzel, A., Chiu, R., Fujita, M., Garcia, F., Bhattarai, P., Patel, R., Buonfiglioli, A., Idiarte, J., Herm...> ;Biorxiv. 2024 Feb 6
- Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.Goldberg, A., Dovas, A., Torres, D., Sharma, S., Mela, A., Merricks, E., Olabarria, M., Shokooh, L., Zhao, H., Kotidis, C., Calvaresi, P., Viswanathan, A., Banu, M., R...> ;Biorxiv. 2024 Jan 21
- Extent of resection for low-grade gliomas - Prognostic or therapeutic?Garton, A., Rae, A., Kocakavuk, E., Kinslow, C., McKhann, G., Cheng, S., Sisti, M., Bruce, J., Wang, T.> ;Clinical Neurology and Neurosurgery. 2024 Jan 1
- Join now to see all
Journal Articles
- De Novo Gene Signature Identification from Single‐Cell RNA‐Seq with Hierarchical Poisson FactorizationPeter Canoll, Jeffrey N Bruce, Molecular Systems Biology
Authored Content
- Recently Viewed (1) Article Information Headings References TrendMD Related Metrics PubMed Google ScholarDecember 2018
- Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-Analysis RelatedApril 2018
- Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-AnalysisApril 2018
Press Mentions
- Implant Delivers Chemo Directly to Brain in Patients Battling Brain TumorsNovember 22nd, 2022
- Brain Cancer Implant Is Shown to Safely Deliver Chemotherapy Directly to the OrganNovember 16th, 2022
- Implanted Pump Safely Delivered Chemo Straight to the Brain in Patients with Brain CancerNovember 10th, 2022
- Join now to see all
Grant Support
- Topotecan By Intracerebral Clysis For Brain TumorsNational Cancer Institute2002–2006
- Topotecan By Intracerebral Clysis /Treatment Of Primary Malignant BraintumorNational Center For Research Resources2005
- Recombinant Chimeric Protein For Recurrent AstrocytomaNational Center For Research Resources2000–2002
- Intratumoral/Interstitial Therapy With Hn-6600 In Refracotry GlioblastomaNational Center For Research Resources1998–2000
- CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1995–1997
- Brain Tumor Research CenterNational Cancer Institute1995
- CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1994
- Brain Tumor Research CenterNational Cancer Institute1994
Professional Memberships
- Member
- Member
- Fellow
- Member
- Member
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Lifewise Health Plan of Oregon
Multiplan PHCS PPOMultiplan PPO
MVP Healthcare PPO
ODS Network
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
PacificSource Preferred PSN
Providence Health System Personal Option
Providence Health System Preferred PPO
Regence Oregon - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: